KUALA LUMPUR (Sept 2): A subsidiary of Bintai Kinden Corp Bhd, Bintai Healthcare Sdn Bhd is teaming up with hemodialyzer manufacturer Scientillence Sdn Bhd for hemodialysis business in Malaysia and Southeast Asia.
In a statement, the group said the companies had signed a business collaboration agreement to jointly develop and market medical products in the hemodialysis market, as well as to develop, invest, acquire or own dialysis centres and other related renal care businesses in Malaysia and Southeast Asia.
Bintai Kinden executive director Azri Azerai said the partnership will facilitate the group to tap into the hemodialysis market as part of its business strategies to widen its range of products and services, including distribution of medical devices and healthcare solutions in Malaysia.
“Pursuant to the agreement, both Bintai Healthcare and Scientillence will work together to explore and identify suitable new markets to expand and distribute Scientillence’s products and other products in the private and commercial sector, such as non-governmental organisations (NGOs),” he said.
Meanwhile, Scientillence as the manufacturer of the hemodialyzer in Malaysia and Southeast Asia will be providing all necessary technical support and services in relation to the marketing and selling of the product.
Scientillence is owned by ex-chief executive officer (CEO) and chairman of hospital group Pantai Holdings Bhd Tan Sri Lim Tong Yong.
The company has obtained Quality Management System accreditation for its manufacturing business and various certifications for its products. It is also in the registration process for CE (Conformite European) and the first “halal”-certified dialyzer manufacturer in the world.
Currently, Scientillence’s products are exported mainly to China, India, Pakistan, Bangladesh, Saudi Arabia, Turkey, Lebanon and most of the Southeast Asia countries.
Meanwhile, Bintai Healthcare is registered with the Medical Device Authority (MDA) as an authorised representative, distributor and importer of medical devices in Malaysia.
Moving forward, Bintai Kinden said, the agreement is not expected to have any material effect on the issued and paid-up share capital of the group, but is expected to contribute positively towards its future earnings.
Shares in Bintai Kinden jumped to a seven-month high of 58 sen in morning trade today. At the 12.30pm break, the stock was down four sen or 7.08% at 52.5 sen, giving it a market capitalisation of RM200.49 million, with some 73.16 million shares traded.
http://www.theedgemarkets.com/article/bintai-kinden-unit-inks-collaboration-hemodialysis-business-malaysia-southeast-asia
